<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="(http://creativecommons.org/licenses/by/4.0/). Abstract Taro corms contain valuable bioactive molecules effective against" exact="cancer" post="and cancer-related risk factors, such as carcinogens and biological"/>
 <result pre="and gluten-intolerant individuals, while contributing to reduce the risk of" exact="obesity" post="and type II diabetes. In addition, the presence of"/>
 <result pre="dietary fibers can improve intestinal transit and possibly aid in" exact="colorectal cancer" post="prevention. As a result of its gluten-free nature, taro"/>
 <result pre="fibers can improve intestinal transit and possibly aid in colorectal" exact="cancer" post="prevention. As a result of its gluten-free nature, taro"/>
 <result pre="of other physiopathological conditions that compose the risk factors for" exact="cancer" post="burden, including obesity and type II diabetes. 1.3. Risk"/>
 <result pre="conditions that compose the risk factors for cancer burden, including" exact="obesity" post="and type II diabetes. 1.3. Risk Factors Associated with"/>
 <result pre="to 804,100 new cases in 2012 [30]. The risk of" exact="cancer" post="is directly associated with both intrinsic and non-intrinsic factors."/>
 <result pre="as spontaneous modifications in DNA that can contribute to the" exact="cancer" post="initiation process. Non-intrinsic elements are entirely modifiable and comprehend"/>
 <result pre="and genome integrity triggered by biological aging, genetic susceptibility (heritable" exact="cancer" post="genes), hormone and growth factor levels, metabolic dysfunctions, chronic"/>
 <result pre="immunological competences. Exogenous agents contribute to about 70% risk of" exact="cancer" post="development compared to endogenous factors, by causing new mutations,"/>
 <result pre="human papillomavirus (HPV), with cervical, head and neck cancers, and" exact="hepatitis" post="virus B and C, with hepatocellular carcinoma. Mutagens/carcinogenic agents"/>
 <result pre="and neck cancers, and hepatitis virus B and C, with" exact="hepatocellular carcinoma." post="Mutagens/carcinogenic agents comprise environmental physical or chemical agents such"/>
 <result pre="linked to dietary habits such as type II diabetes and" exact="obesity" post="are among the exogenous risk factors frequently associated with"/>
 <result pre="obesity are among the exogenous risk factors frequently associated with" exact="cancer" post="cases [33,34]. On the other hand, a diet including"/>
 <result pre="and greens is highly associated with a reduced risk of" exact="cancer" post="development in humans [31,35,36,37]. These food sources are widely"/>
 <result pre="antimetastatic, and antitumoral activities which, together, can contribute to delay" exact="cancer" post="burden, since they prevent oxidative stress, modulate the proinflammatory"/>
 <result pre="effect of multiple compounds displaying effectiveness not only against several" exact="cancer" post="cell lines but also against some of the main"/>
 <result pre="cell lines but also against some of the main external" exact="cancer" post="risk factors, such as free radicals, mutagenic and carcinogenic"/>
 <result pre="radicals, mutagenic and carcinogenic agents, and physiopathological conditions such as" exact="obesity" post="and type II diabetes (Table 2). Interestingly, many of"/>
 <result pre="healthy eating habits, could contribute to the efforts to reduce" exact="cancer" post="risks. 2.1. Taro Antioxidants Antioxidants, under appropriate concentrations, protect,"/>
 <result pre="TNF-Î±, two critical factors that, when upregulated, may participate in" exact="cancer" post="development. Thus, polyphenols could aid in controlling cancer progression"/>
 <result pre="participate in cancer development. Thus, polyphenols could aid in controlling" exact="cancer" post="progression due to their anti-inflammatory effects, including the activation"/>
 <result pre="studies have indicated that reactive oxygen species (ROS) scavenging in" exact="cancer" post="cells, particularly during chemotherapy, interferes with the primary mechanism,"/>
 <result pre="double-edged sword. To be used as a supportive therapy during" exact="cancer" post="treatments, it might take into account the type of"/>
 <result pre="vegetables and fruits, since their protective effects against gastric and" exact="colorectal cancer" post="risks have been demonstrated by several reports, including meta-analysis"/>
 <result pre="and fruits, since their protective effects against gastric and colorectal" exact="cancer" post="risks have been demonstrated by several reports, including meta-analysis"/>
 <result pre="compounds can reduce the risk of gastrointestinal tract cancers. Nevertheless," exact="cancer" post="risk reduction by dietary fiber intake can be extended"/>
 <result pre="traditionally consumed by Hawaiians, inhibits the proliferation of rat YYT" exact="colon cancer" post="cells in a dose-dependent manner, reaching its maximum effect"/>
 <result pre="consumed by Hawaiians, inhibits the proliferation of rat YYT colon" exact="cancer" post="cells in a dose-dependent manner, reaching its maximum effect"/>
 <result pre="(APC) activation, in order to promote the direct destruction of" exact="cancer" post="cells. CD4+ T lymphocytes contribute to the fight against"/>
 <result pre="cancer cells. CD4+ T lymphocytes contribute to the fight against" exact="cancer" post="by the release of pro-inflammatory cytokines IL-2, TNF-Î±, and"/>
 <result pre="to both a direct effect of its bioactive compounds on" exact="cancer" post="cells associated with an indirect effect on immune system"/>
 <result pre="taro extract inhibits the in vitro proliferation of several human" exact="breast cancer" post="lines, i.e., MCF-7, MDA-MB-231, and MCF10A, as well as"/>
 <result pre="extract inhibits the in vitro proliferation of several human breast" exact="cancer" post="lines, i.e., MCF-7, MDA-MB-231, and MCF10A, as well as"/>
 <result pre="lines, i.e., MCF-7, MDA-MB-231, and MCF10A, as well as murine" exact="breast cancer" post="lines 66.1, 410.4, and EpH4. The antiproliferative effects on"/>
 <result pre="i.e., MCF-7, MDA-MB-231, and MCF10A, as well as murine breast" exact="cancer" post="lines 66.1, 410.4, and EpH4. The antiproliferative effects on"/>
 <result pre="therapeutic and protective effects against heart and lung colonization by" exact="breast cancer" post="lineages [42]. The anticancer effects promoted by taro extract"/>
 <result pre="and protective effects against heart and lung colonization by breast" exact="cancer" post="lineages [42]. The anticancer effects promoted by taro extract"/>
 <result pre="improved anticancer activity compared to the free protein against human" exact="breast cancer" post="(MDA-MB-231) and glioblastoma (U87 MG) lineages, resulting in 41"/>
 <result pre="anticancer activity compared to the free protein against human breast" exact="cancer" post="(MDA-MB-231) and glioblastoma (U87 MG) lineages, resulting in 41"/>
 <result pre="that are part of antigens found in many types of" exact="cancer" post="cells, such as CA-125 in ovarian cancer, paucimannose in"/>
 <result pre="in many types of cancer cells, such as CA-125 in" exact="ovarian cancer," post="paucimannose in human cancerous cells, Lewis-y epitope, a typical"/>
 <result pre="found in the colon, stomach, ovary, breast, pancreas, prostate and" exact="lung cancer," post="hematopoietic progenitor cells, peripheral blood granulocytes, and to the"/>
 <result pre="extracts have also demonstrated anti-inflammatory activity against human and murine" exact="breast cancer" post="cells by modulating the immune response through the reduction"/>
 <result pre="have also demonstrated anti-inflammatory activity against human and murine breast" exact="cancer" post="cells by modulating the immune response through the reduction"/>
 <result pre="effects, contributing to (i) the generation of additional mutations in" exact="cancer" post="cells by stimulating the release of ROS; (ii) upregulation"/>
 <result pre="kinase (ERK) and membrane proteases also involved in invasion; (iii)" exact="suppression" post="of antitumoral response by downregulating the immune system; (iv)"/>
 <result pre="cell proliferation and survival. As a result, the angiogenesis process," exact="cancer" post="cell proliferation, differentiation, and migration would be prevented [42,118,119,120]."/>
 <result pre="inhibition of COX-2 resulted in an overall 70% reduction in" exact="cancer" post="risk for breast, lung, prostate and, colon cancers, and"/>
 <result pre="COX-2 by taro lectin seems to be very promising in" exact="cancer" post="treatment, since the reduction in PGE2 synthesis attenuates pro-tumorigenesis."/>
 <result pre="condition in cancer. GNA-related lectins exert their cytotoxic activities on" exact="cancer" post="cells mainly by deactivating rat sarcoma-rapidly accelerated fibrosarcoma (Rasâ€&quot;Raf)"/>
 <result pre="activities on cancer cells mainly by deactivating rat sarcoma-rapidly accelerated" exact="fibrosarcoma" post="(Rasâ€&quot;Raf) and PI3Kâ€&quot;Akt pathways previously activated by PGE2 autocrine"/>
 <result pre="1-4 (EP1-4) receptor, inhibiting the proliferation, migration/invasion, and survival of" exact="cancer" post="cells. Once the anti-apoptotic pathways are inhibited, cell death"/>
 <result pre="which could be an indirect way to contribute to reducing" exact="cancer" post="risk or controlling tumorigenesis (Figure 4). Indeed, in mice,"/>
 <result pre="system in healthy individuals or to accelerate the recovery from" exact="leukopenia" post="in immunosuppressed patients, including those under chemotherapy. Tarin immunomodulatory"/>
 <result pre="from freeze-dried taro exhibited an antiproliferative effect against adult T-cells" exact="leukemia" post="lineages and, in some of them, effectiveness was superior"/>
 <result pre="healthier lifestyle is the recommended strategy to prevent overweight or" exact="obesity" post="and avoid cancers related to these comorbidities [128,129,130]. Taro"/>
 <result pre="demonstrated in clinical trials, being considered adequate for diabetes and" exact="obesity" post="control, since they share similar mechanisms of action with"/>
 <result pre="in vitro, thus being potentially able to control diabetes and" exact="obesity" post="[57]. The inhibition of starch-hydrolytic enzymes by taro compounds"/>
 <result pre="that are associated with a decrease in the risk of" exact="kidney cancer" post="death [142,143,144]. Taken together, the intake of taro or"/>
 <result pre="are associated with a decrease in the risk of kidney" exact="cancer" post="death [142,143,144]. Taken together, the intake of taro or"/>
 <result pre="diseases, which are important causes of death worldwide, along with" exact="cancer" post="[145,146]. Moreover, the overall benefit against type II diabetes"/>
 <result pre="[145,146]. Moreover, the overall benefit against type II diabetes and" exact="obesity" post="could certainly aid in reducing the risk factors for"/>
 <result pre="modulation of cellular proliferation, differentiation, apoptosis, angiogenesis, and invasion of" exact="cancer" post="cells. The antiproliferative and apoptosis-inducing activities in tumorigenic cells"/>
 <result pre="taro corms? How can taro corm bioactive compounds contribute to" exact="cancer" post="fighting or prevention? What could be the benefits provided"/>
 <result pre="were excluded when presenting: Biological activities not directly related to" exact="cancer" post="fighting or prevention and cancer risk factors (antimicrobial, anti-insect,"/>
 <result pre="activities not directly related to cancer fighting or prevention and" exact="cancer" post="risk factors (antimicrobial, anti-insect, antiviral, anti-helminthic, and others) for"/>
 <result pre="or clinical trial) that analyzed biological properties considered important for" exact="cancer" post="fighting or prevention, such as antioxidant, antitumoral, antimetastatic, immunomodulatory,"/>
 <result pre="Rev. Food Sci. Food Saf.2006511710.1111/j.1541-4337.2006.tb00076.x33412740 30.Pearson-StuttardJ.ZhouB.KontisV.BenthamJ.GunterM.J.EzzatiM.Retraction and republicationâ€&quot;Worldwide burden of" exact="cancer" post="attributable to diabetes and high body-mass index: A comparative"/>
 <result pre="A comparative risk assessmentLancet Diabetes Endocrinol.20186S2213S858710.1016/S2213-8587(17)30366-2 31.WuS.ZhuW.ThompsonP.HannunY.A.Evaluating intrinsic and non-intrinsic" exact="cancer" post="risk factorsNat. Commun.20189349010.1038/s41467-018-05467-z30154431 32.WuS.PowersS.ZhuW.HannunY.A.Substantial contribution of extrinsic risk factors"/>
 <result pre="risk factorsNat. Commun.20189349010.1038/s41467-018-05467-z30154431 32.WuS.PowersS.ZhuW.HannunY.A.Substantial contribution of extrinsic risk factors to" exact="cancer" post="developmentNature20165294310.1038/nature1616626675728 33.BamiaC.Dietary patterns in association to cancer incidence and"/>
 <result pre="risk factors to cancer developmentNature20165294310.1038/nature1616626675728 33.BamiaC.Dietary patterns in association to" exact="cancer" post="incidence and survival: Concept, current evidence, and suggestions for"/>
 <result pre="Clin. Nutr.20187281882510.1038/s41430-018-0128-829563640 34.LiY.SchoufourJ.WangD.D.DhanaK.PanA.LiuX.SongM.LiuG.ShinH.J.SunQ.Healthy lifestyle and life expectancy free of cancer," exact="cardiovascular disease," post="and type 2 diabetes: Prospective cohort studyBMJ20203681666910.1136/bmj.l6669 35.SteckS.E.MurphyE.A.Dietary patterns"/>
 <result pre="and type 2 diabetes: Prospective cohort studyBMJ20203681666910.1136/bmj.l6669 35.SteckS.E.MurphyE.A.Dietary patterns and" exact="cancer" post="riskNat. Rev. Cancer20192012513810.1038/s41568-019-0227-431848467 36.ClintonS.K.GraingerE.M.GiovannucciE.L.Diet and Nutrition in the Etiology"/>
 <result pre="Prevention of CancerHoll. Frei. Cancer Med.201612110.1002/9781119000822.hfcm037 37.VanamalaJ.Food systems approach to" exact="cancer" post="preventionCrit. Rev. Food Sci. Nutr.2017572573258810.1080/10408398.2015.102802326192392 38.DavisC.D.RossS.Diet and cancer preventionLifestyle"/>
 <result pre="approach to cancer preventionCrit. Rev. Food Sci. Nutr.2017572573258810.1080/10408398.2015.102802326192392 38.DavisC.D.RossS.Diet and" exact="cancer" post="preventionLifestyle Medicine3rd ed.RippeJ.M.CRC Press Taylor &amp;amp; Francis GroupNew York,"/>
 <result pre="peppersPlant Foods Hum. Nutr.20126712012810.1007/s11130-012-0290-422569831 90.CollinsA.R.Antioxidant intervention as a route to" exact="cancer" post="preventionEur. J. Cancer2005411923193010.1016/j.ejca.2005.06.00416111883 91.BellikY.BoukraÃ¢L.AlzahraniH.A.BakhotmahB.A.AbdellahF.HammoudiS.M.Iguer-OuadaM.Molecular mechanism underlying anti-inflammatory and anti-allergic"/>
 <result pre="activities of phytochemicals: An updateMolecules20131832210.3390/molecules18010322 92.KhanH.UllahH.CastilhoP.C.M.F.GomilaA.S.Dâ€™OnofrioG.FilosaR.WangF.NabaviS.M.DagliaM.SilvaA.S.Targeting NF-ÎºB signaling pathway in" exact="cancer" post="by dietary polyphenolsCrit. Rev. Food Sci. Nutr.2019602790280010.1080/10408398.2019.166182731512490 93.DewantoV.WuX.LiuR.H.Processed sweet"/>
 <result pre="16 April 2020) 110.ZengH.LazarovaD.L.BordonaroM.Mechanisms linking dietary fiber, gut microbiota and" exact="colon cancer" post="preventionWorld J. Gastrointest. Oncol.201464110.4251/wjgo.v6.i2.4124567795 111.KohA.De VadderF.Kovatcheva-DatcharyP.BÃ¤ckhedF.From Dietary Fiber to"/>
 <result pre="April 2020) 110.ZengH.LazarovaD.L.BordonaroM.Mechanisms linking dietary fiber, gut microbiota and colon" exact="cancer" post="preventionWorld J. Gastrointest. Oncol.201464110.4251/wjgo.v6.i2.4124567795 111.KohA.De VadderF.Kovatcheva-DatcharyP.BÃ¤ckhedF.From Dietary Fiber to"/>
 <result pre="120.Hashemi GoradelN.NajafiM.SalehiE.FarhoodB.MortezaeeK.Cyclooxygenase-2 in cancer: A reviewJ. Cell. Physiol.20192345683569910.1002/jcp.2741130341914 121.HarrisR.E.BeebeJ.AlshafieG.A.Reduction in" exact="cancer" post="risk by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsJ. Exp."/>
 <result pre="USA2017Volume 1221241 127.YamasakiM.MukaiA.OhbaM.MineY.SakakibaraY.SuikoM.MorishitaK.NishiyamaK.Genistein induced apoptotic cell death in adult T-cell" exact="leukemia" post="cells through estrogen receptorsBiosci. Biotechnol. Biochem.2010742113211510.1271/bbb.10035920944417 128.GarcÃ­a-JimÃ©nezC.GutiÃ©rrez-SalmerÃ³nM.Chocarro-CalvoA.GarcÃ­a-MartinezJ.M.CastaÃ±oA.De la ViejaA.From"/>
 <result pre="leukemia cells through estrogen receptorsBiosci. Biotechnol. Biochem.2010742113211510.1271/bbb.10035920944417 128.GarcÃ­a-JimÃ©nezC.GutiÃ©rrez-SalmerÃ³nM.Chocarro-CalvoA.GarcÃ­a-MartinezJ.M.CastaÃ±oA.De la ViejaA.From" exact="obesity" post="to diabetes and cancer: Epidemiological links and role of"/>
 <result pre="index and glycemic load foods as panacea for type 2" exact="diabetes mellitus;" post="prospects, challenges and solutionsAfr. Health Sci.20161646847910.4314/ahs.v16i2.1527605962 142.WashioM.MoriM.SakauchiF.WatanabeY.OzasaK.HayashiK.MikiT.NakaoM.MikamiK.ItoY.Risk factors for"/>
 <result pre="mellitus; prospects, challenges and solutionsAfr. Health Sci.20161646847910.4314/ahs.v16i2.1527605962 142.WashioM.MoriM.SakauchiF.WatanabeY.OzasaK.HayashiK.MikiT.NakaoM.MikamiK.ItoY.Risk factors for" exact="kidney cancer" post="in a Japanese population: Findings from the JACC StudyJ."/>
 <result pre="prospects, challenges and solutionsAfr. Health Sci.20161646847910.4314/ahs.v16i2.1527605962 142.WashioM.MoriM.SakauchiF.WatanabeY.OzasaK.HayashiK.MikiT.NakaoM.MikamiK.ItoY.Risk factors for kidney" exact="cancer" post="in a Japanese population: Findings from the JACC StudyJ."/>
 <result pre="from the JACC StudyJ. Epidemiol.200515S203S21110.2188/jea.15.S20316127235 143.WashioM.MoriM.Risk factors for renal cell" exact="cancer" post="in a Japanese populationClin. Med. Oncol.20093717510.4137/CMO.S266920689612 144.WashioM.MoriM.MikamiK.MikiT.WatanabeY.NakaoM.KuboT.SuzukiK.OzasaK.WakaiK.Risk factors for"/>
 <result pre="cancer in a Japanese populationClin. Med. Oncol.20093717510.4137/CMO.S266920689612 144.WashioM.MoriM.MikamiK.MikiT.WatanabeY.NakaoM.KuboT.SuzukiK.OzasaK.WakaiK.Risk factors for" exact="renal cell carcinoma" post="in a Japanese populationAsian Pac. J. Cancer Prev.2014159065907010.7314/APJCP.2014.15.21.906525422180 145.TeramotoT.YokodeM.IsoH.KitamuraA.ShiomiH.KimuraT.MatsumotoM.IidaM.SasakiJ.InoueS.et"/>
 <result pre="pathway could be mediated by polyphenols. Polyphenols can mediate the" exact="suppression" post="of NF-ÎºB transcriptional factor resulting in the inhibition of"/>
 <result pre="kappa B kinase (IKK); vascular endothelial growth factor (VEGF); B-cell" exact="lymphoma" post="2 (BCL-2); B-cell lymphoma X (BCL-X); c-myelocytomatosis (C-MYC). Figure"/>
 <result pre="vascular endothelial growth factor (VEGF); B-cell lymphoma 2 (BCL-2); B-cell" exact="lymphoma" post="X (BCL-X); c-myelocytomatosis (C-MYC). Figure 3 Putative targets of"/>
 <result pre="panel) Tarin binds to specific carbohydrate antigens, typically overexpressed in" exact="cancer" post="cells, down-regulating COX-2 (cyclooxygenase 2) expression, culminating in decreased"/>
 <result pre="poi extract - - In vitro Inhibition of rat YYT" exact="colon cancer" post="cells (nearly 80â€&quot;90%) [41] USA Crude taro extract Protein"/>
 <result pre="extract - - In vitro Inhibition of rat YYT colon" exact="cancer" post="cells (nearly 80â€&quot;90%) [41] USA Crude taro extract Protein"/>
 <result pre="Crude taro extract Protein Tarin In vitro Inhibition of murine" exact="breast cancer" post="cell lines: 66.1 (54%), 410.4 (24%) and EpH4 (21%)"/>
 <result pre="taro extract Protein Tarin In vitro Inhibition of murine breast" exact="cancer" post="cell lines: 66.1 (54%), 410.4 (24%) and EpH4 (21%)"/>
 <result pre="(54%), 410.4 (24%) and EpH4 (21%) [42] Inhibition of human" exact="breast cancer" post="cell lines: MCF-7 (65%), MDA-MB-231 (26%), MCF10A (31%) Reduction"/>
 <result pre="410.4 (24%) and EpH4 (21%) [42] Inhibition of human breast" exact="cancer" post="cell lines: MCF-7 (65%), MDA-MB-231 (26%), MCF10A (31%) Reduction"/>
 <result pre="[43] China Tarin nano-liposomal capsules In vitro Inhibition of human" exact="breast cancer" post="MDA-MB-231 (41%) [44] Brazil Inhibition of human Glioblastoma U87"/>
 <result pre="China Tarin nano-liposomal capsules In vitro Inhibition of human breast" exact="cancer" post="MDA-MB-231 (41%) [44] Brazil Inhibition of human Glioblastoma U87"/>
 <result pre="extract - - In vitro Inhibition of various adult T-cells" exact="leukemia" post="(ATL) lineages IC50 from 25 to 106.9 Î¼g/mL [46]"/>
 <result pre="repopulation of BM granulocytic Gr1+ cells In vivo Attenuation of" exact="leukopenia" post="in immunosuppressed mice Enhancement of BM granulocytic progenitors Proliferation/differentiation"/>
</results>
